Exam 3 - Lecture 2 (upper respiratory tract infections) Flashcards
most common pathogens for URTI
many respiratory viruses
acute bronchitis tx
no abx needed
no corticosteroids needed
-self limiting
acute exacerbation of chronic bronchitis s/sx
- increased sputum purulence
- increased sputum volume
- increased cough or SOB
most common organisms for acute exacerbation of chronic bronchitis
strep pneumo
H. flu
M. cat
acute exacerbation of chronic bronchitis preferred tx and duration
aug
cefuroxime
cefpodoxime
*duration 5-7 days
acute exacerbation of chronic bronchitis alternative tx and duration
doxy
bactrim
azithro
*duration 5-7 days
acute exacerbation of chronic bronchitis pseudomonas risk tx and duration
levofloxacin
duration of 5-7 days
acute pharyngitis common pathogens
viruses (rhino, corona, adeno)
bacteria - strep pyogenes (group A)
acute pharyngitis preferred tx
and tx duration
target group A strep (pyogenes)
-pen VK
-amox
*typically 10 days
acute pharyngitis alternative tx
and tx duration
if penicillin allergy:
non-anaphylactic rxn:
-cephalexin
-cefadroxil
-cefuroxime
-cefpodoxime
anaphylactic rxn:
-azithromycin
-clindamycin
*typically 10 days (besides azithromycin 5 day course)
acute bacterial rhinosinusitis (ABRS) symptoms description
-persistent sx 10 days or more with no improvement
-severe sx: fever, puru;ent discharge, facial pain for 3-4 consecutive days at beginning of illness
-worsening sx: new onset of sx after initial improvement in sx
acute bacterial rhinosinusitis 1st line tx
- watchful waiting until bacterial infection established, then:
-aug 500/125 x 5-7 days
-aug 2000/125 x 5-7 days if concerned for penicillin resistance
acute bacterial rhinosinusitis 2nd line tx
doxy
levo
moxi
*5-7 days duration
acute bacterial rhinosinusitis MRSA concern tx
add MRSA coverage like:
-doxy
-bactrim
-linezolid
-clindamycin
acute bacterial rhinosinusitis pseudomonas tx
levo
acute bacterial rhinosinusitis supportive care
NSAIDs/APAP
intranasal saline irrigation
warm facial packs
hydrate
avoid antihistamines
caution with decongestants due to rebound congestion